ProCE Banner Activity

Molecular Testing Overview and Biomarkers Predicting Response to Immune-Based Therapies in NSCLC

Slideset Download
Download these slides from a live CCO Webinar for an overview of biomarker testing in advanced NSCLC along with the current status of biomarkers guiding optimal use of immunotherapy for the treatment of this disease.

Released: June 28, 2021

Expiration: June 27, 2022

No longer available for credit.

Share

Faculty

Stephen Liu

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Suresh S. Ramalingam

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Turning Point Therapeutics Inc

Faculty Disclosure

Primary Author

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia